Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mark Ping Chao0

Jens-Peter Volkmer0

Chris Hidemi Mizufune Takimoto0

Date of Patent

February 6, 2024

0

Patent Application Number

162723500

Date Filed

February 11, 2019

0

Patent Citations

US Patent 9352037 Compositions and methods to enhance the immune system

0

US Patent 9790275 Compositions and methods to enhance the immune system

0

US Patent 10081680 Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies

0

US Patent 9920122 Compositions and methods to enhance the immune system

0

US Patent 10287351 Compositions and methods to enhance the immune system

0

US Patent 8728476 Compositions and methods to enhance the immune system

0

US Patent 8758750 Synergistic anti-CD47 therapy for hematologic cancers

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

Methods, kits, and compositions are provided herein that can be used to treat CD20+ cancer using an anti-CD47 agent such as an antibody. The anti-CD47 agent can be used alone or in combination with one or more additional agent such as an anti-CD20 antibody.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool